financetom
Personal Finance
financetom
/
Personal Finance
/
TATA AIG launches 'Health Supercharge' with sum insured ranging from ₹5 lakh to ₹20 lakh
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TATA AIG launches 'Health Supercharge' with sum insured ranging from ₹5 lakh to ₹20 lakh
Nov 29, 2023 9:31 AM

TATA AIG General Insurance Company has launched “Health Supercharge” with a sum insured ranging from ₹5 lakh to ₹20 lakh. Customers can choose from options of two plan variants (Value Plan and Geo Plan), basis their geographical location, and other optional benefits offered under the product as per one’s requirement.

Live TV

Loading...

Speaking about the new health insurance policy – TATA AIG Health Supercharge, Santosh Puri, Senior Vice President – Health Product & Process, TATA AIG General Insurance said, “With the launch of Health Supercharge, we will be able to provide policyholders with 5X more coverage for their well-being."

Key highlights of Tata AIG Health Supercharge include:

The product introduces an enhanced level of coverage through a 5X supercharge bonus. This policy offers on each renewal a bonus of 50% of base sum insured of the expiring policy and accumulating maximum bonus up to 500% of the base sum insured in any policy year irrespective of claims.

Families below the age of 40 years or below at the time of first policy inception can benefit from an extra 5% discount which is also applicable upon policy renewals, irrespective of claims, the insurance company said.

The policy offers tailored flexibility with two plan variants (Value Plan & Geo Plan), and optional benefits such as unlimited restore, reduction of Pre-Existing Disease (PED) waiting period for named ailments.

Preventive annual health check-up can be availed by the insured persons once in a policy year, irrespective of claims, by paying an additional premium.

(Edited by : Anshul)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Sell Opinion On Shares Of Penske Automotive Group, Inc.
Research Alert: CFRA Maintains Sell Opinion On Shares Of Penske Automotive Group, Inc.
Aug 1, 2025
08:10 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month price target by $10 to $130, based on a 2026 P/E of 9.0x - a justified discount to the stock's five-year average forward P/E of 9.3x....
Research Alert: CFRA Maintains Hold Opinion On Shares Of Logitech International S.a.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Logitech International S.a.
Aug 1, 2025
11:10 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $100, on 19x our CY 2026 EPS view of $5.25, below its three-year historical average of 23x. We lift our FY 26 EPS view...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Bxp, Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Bxp, Inc.
Aug 1, 2025
12:30 PM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our target by $2 to $64, 8.8x our 2026 FFO estimate, near office peers as hybrid work trends persist and vacancies rise, mixed with negative rental spreads on...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Hologic, Inc.
Research Alert: CFRA Keeps Sell Opinion On Shares Of Hologic, Inc.
Aug 1, 2025
01:30 PM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target price to $58 from $45, 12.8x our FY 26 (Sep.) EPS estimate, a discount to HOLX's historical forward average due to softness in the Breast...
Copyright 2023-2025 - www.financetom.com All Rights Reserved